Atherosclerosis  >>  niacin extended-release formulation  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
niacin extended-release formulation / Generic mfg.
MCAT, NCT00804843: Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)

Completed
2
100
US
Atorvastatin/niacin extended-release, Lipitor, Niaspan, Atorvastatin, Lipitor, Simvastatin, Zocor
Merck Sharp & Dohme LLC
Carotid Atherosclerosis
10/10
10/10

Download Options